$6.470
0.000 (0.00%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 Sinovac Biotech Ltd 股票吗？
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA 股价于 Friday 收于 $6.47，此前上涨 0.00%
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
预测驱动因素
Sinovac Biotech Ltd（SVA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
SVA 季节性分析
Historically the probability of a positive September return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。